Trials / Unknown
UnknownNCT05316675
Impact of Isotretinoin in Different Doses on Quality of Life
Impact of Different Protocols of Systemic Isotretinoin in Acne Treatment on Quality of Life Among Egyptien Patients:Avalidity and Reliability Study
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- 12 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The Cardiff Acne Disability Index is a short five-item questionnaire derived from the longer Acne Disability Index.It is designed for use in teenagers and young adults with acne. It is self explanatory and can be simply handed to the patient who is asked to complete it without the need for detailed explanation( .Abdelrazik etal., 2021). .
Detailed description
Lower doses of isotretinoin can be effective in terms of cost and decreasing systemic side effects. Therefore, other regimens may be used instead of daily conventional dose as alternate, pulse and low doses of oral isotretinoin in acne vulgaris( Agarwal et al., 2011). To study the impact of different protocols of systemic isotretinoin in acne treatment on quality of life among egyptian patients using Cardiff Acne Disability Index (CADI) and dermatology life quality index (DLQI)questionnaires. To assess validity and reliability of the translated Arabic version of CADI. To compare the clinical efficacy and tolerability of different protocols of systemic isotretinoin in acne treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Isotretinoin | isotretinoin 13-cis-retinoic acid), derived from vitamin A |
Timeline
- Start date
- 2022-12-01
- Primary completion
- 2024-10-01
- Completion
- 2024-12-01
- First posted
- 2022-04-07
- Last updated
- 2022-04-07
Source: ClinicalTrials.gov record NCT05316675. Inclusion in this directory is not an endorsement.